Logo image
In vitro and in vivo efficacy of epsiprantel against Echinococcus granulosus
Journal article   Peer reviewed

In vitro and in vivo efficacy of epsiprantel against Echinococcus granulosus

R.C.A. Thompson, J.A. Reynoldson and B.R. Manger
Research in Veterinary Sciench, Vol.51(3), pp.332-334
1991
url
Link to Published Version *Subscription may be requiredView

Abstract

In vitro, epsiprantel at a concentration of 10 μg ml−1 caused tegumental damage and death of protoscoleces, juveniles (seven-day-old) and adult (37-day-old) Echinococcus granulosus. Degenerative changes and death occurred more rapidly in the older parasites. Similarly, epsiprantel was more effective against adult (28-day-old) than seven-day-old experimental infections of E granulosus in dogs. Oral doses of 2·5, 5 and 7·5 mg kg−1 were greater than 96 per cent, 99·9 per cent and 99·99 per cent active, respectively, against mature worms, whereas in seven-day-old infections doses of 5, 7·5 and 10 mg kg−1 produced greater than 94 per cent, 90 per cent and 99·8 per cent reduction in worm burdens, respectively. No side effects from treatment were seen.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.163 Parasitology - General
1.163.1106 Echinococcosis
Web Of Science research areas
Veterinary Sciences
ESI research areas
Plant & Animal Science
Logo image